Overexpression Of Aldh6a1 Rescues Osteoblasts And Facilitates Osseointegration In Hyperlipidemia

Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the potential role of ALDH6A1 in osseointegration in hyperlipidemia mice. The animal experimental procedures were approved by the Medical Ethics Commit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International dental journal Ročník 75; s. 105608
Hlavní autoři: Wang, Ya-nan, Liu, Shiyue
Médium: Journal Article
Jazyk:angličtina
Vydáno: Elsevier Inc 01.10.2025
Elsevier
Témata:
ISSN:0020-6539
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the potential role of ALDH6A1 in osseointegration in hyperlipidemia mice. The animal experimental procedures were approved by the Medical Ethics Committee of Stomatological Hospital, Shandong University, Jinan, China. Twenty-four 6-week-old male C57BL/6J mice were used to construct normal or hyperlipidemia femoral implant model, and overexpression of ALDH6A1 was achieved through local injection of lentivirus. Micro-CT and immunofluorescence staining were applied to detect osseointegration, oxidative damage, expression levels of ALDH6A1 in peri-implant tissue. In addition, primary osteoblasts from mouse skull were extracted and cultured for exploring the impact of changes in ALDH6A1 expression levels on the biological activity of osteoblasts. All data were presented as the mean ± standard deviation of at least three independent experiments. The P value less than 0.05 was considered to be statistically significant. In vivo, ALDH6A1 expression significantly decreased in hyperlipidemia mice, compared with normal mice (P < 0.05), and local overexpression of ALDH6A1 facilitated osseointegration in hyperlipidemia mice by reducing oxidative damage in peri-implant tissue. In vitro, ALDH6A1 was downregulated in high-fat environment and silencing ALDH6A1 led to osteogenic dysfunction. Additionally, ALDH6A1 overexpression reduced the fluorescence intensity of DCFH-DA and MitoSOX, and restored the expression of COLI, ALP, and RUNX2. Overexpression of ALDH6A1 significantly reshapes the biological activity of osteoblasts and improves osseointegration under hyperlipidemia. ALDH6A1 is a potential therapeutic target for hyperlipidemia related bone metabolism diseases.
AbstractList Aim or purposeEndogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the potential role of ALDH6A1 in osseointegration in hyperlipidemia mice. Materials and methodsThe animal experimental procedures were approved by the Medical Ethics Committee of Stomatological Hospital, Shandong University, Jinan, China. Twenty-four 6-week-old male C57BL/6J mice were used to construct normal or hyperlipidemia femoral implant model, and overexpression of ALDH6A1 was achieved through local injection of lentivirus. Micro-CT and immunofluorescence staining were applied to detect osseointegration, oxidative damage, expression levels of ALDH6A1 in peri-implant tissue. In addition, primary osteoblasts from mouse skull were extracted and cultured for exploring the impact of changes in ALDH6A1 expression levels on the biological activity of osteoblasts. All data were presented as the mean ± standard deviation of at least three independent experiments. The P value less than 0.05 was considered to be statistically significant. ResultsIn vivo, ALDH6A1 expression significantly decreased in hyperlipidemia mice, compared with normal mice (P < 0.05), and local overexpression of ALDH6A1 facilitated osseointegration in hyperlipidemia mice by reducing oxidative damage in peri-implant tissue. In vitro, ALDH6A1 was downregulated in high-fat environment and silencing ALDH6A1 led to osteogenic dysfunction. Additionally, ALDH6A1 overexpression reduced the fluorescence intensity of DCFH-DA and MitoSOX, and restored the expression of COLI, ALP, and RUNX2. ConclusionsOverexpression of ALDH6A1 significantly reshapes the biological activity of osteoblasts and improves osseointegration under hyperlipidemia. ALDH6A1 is a potential therapeutic target for hyperlipidemia related bone metabolism diseases.
Aim or purpose: Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the potential role of ALDH6A1 in osseointegration in hyperlipidemia mice. Materials and methods: The animal experimental procedures were approved by the Medical Ethics Committee of Stomatological Hospital, Shandong University, Jinan, China. Twenty-four 6-week-old male C57BL/6J mice were used to construct normal or hyperlipidemia femoral implant model, and overexpression of ALDH6A1 was achieved through local injection of lentivirus. Micro-CT and immunofluorescence staining were applied to detect osseointegration, oxidative damage, expression levels of ALDH6A1 in peri-implant tissue. In addition, primary osteoblasts from mouse skull were extracted and cultured for exploring the impact of changes in ALDH6A1 expression levels on the biological activity of osteoblasts. All data were presented as the mean ± standard deviation of at least three independent experiments. The P value less than 0.05 was considered to be statistically significant. Results: In vivo, ALDH6A1 expression significantly decreased in hyperlipidemia mice, compared with normal mice (P < 0.05), and local overexpression of ALDH6A1 facilitated osseointegration in hyperlipidemia mice by reducing oxidative damage in peri-implant tissue. In vitro, ALDH6A1 was downregulated in high-fat environment and silencing ALDH6A1 led to osteogenic dysfunction. Additionally, ALDH6A1 overexpression reduced the fluorescence intensity of DCFH-DA and MitoSOX, and restored the expression of COLI, ALP, and RUNX2. Conclusions: Overexpression of ALDH6A1 significantly reshapes the biological activity of osteoblasts and improves osseointegration under hyperlipidemia. ALDH6A1 is a potential therapeutic target for hyperlipidemia related bone metabolism diseases.
Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the potential role of ALDH6A1 in osseointegration in hyperlipidemia mice. The animal experimental procedures were approved by the Medical Ethics Committee of Stomatological Hospital, Shandong University, Jinan, China. Twenty-four 6-week-old male C57BL/6J mice were used to construct normal or hyperlipidemia femoral implant model, and overexpression of ALDH6A1 was achieved through local injection of lentivirus. Micro-CT and immunofluorescence staining were applied to detect osseointegration, oxidative damage, expression levels of ALDH6A1 in peri-implant tissue. In addition, primary osteoblasts from mouse skull were extracted and cultured for exploring the impact of changes in ALDH6A1 expression levels on the biological activity of osteoblasts. All data were presented as the mean ± standard deviation of at least three independent experiments. The P value less than 0.05 was considered to be statistically significant. In vivo, ALDH6A1 expression significantly decreased in hyperlipidemia mice, compared with normal mice (P < 0.05), and local overexpression of ALDH6A1 facilitated osseointegration in hyperlipidemia mice by reducing oxidative damage in peri-implant tissue. In vitro, ALDH6A1 was downregulated in high-fat environment and silencing ALDH6A1 led to osteogenic dysfunction. Additionally, ALDH6A1 overexpression reduced the fluorescence intensity of DCFH-DA and MitoSOX, and restored the expression of COLI, ALP, and RUNX2. Overexpression of ALDH6A1 significantly reshapes the biological activity of osteoblasts and improves osseointegration under hyperlipidemia. ALDH6A1 is a potential therapeutic target for hyperlipidemia related bone metabolism diseases.
ArticleNumber 105608
Author Wang, Ya-nan
Liu, Shiyue
Author_xml – sequence: 1
  givenname: Ya-nan
  surname: Wang
  fullname: Wang, Ya-nan
  organization: Department of Implantology & Periodontology, School and Hospital of Stomatology, Shandong University, Jinan, China
– sequence: 2
  givenname: Shiyue
  surname: Liu
  fullname: Liu, Shiyue
  organization: Department of Implantology & Periodontology, School and Hospital of Stomatology, Shandong University, Jinan, China
BookMark eNqVkV1rFDEUhnNRwbb6D7yYP7DrycdkMiDCUqxdKCxUvY6Z5EzNOE2WJC3uvzfTEe9EehU44X1y8rwX5CzEgIS8o7ClQOX7aesdhjJtGbC2jloJ6oycAzDYyJb3r8lFzhOAUBzkOfl-eMKEv44Jc_YxNIex2c3uhzS0ucNsHzE3h1wwDrPJJTe74JprY_3siynPdxmjDwXvkylLfh-am9MR0-yPdY8Hb96QV6OZM779c16Sb9efvl7dbG4Pn_dXu9uN5QzUhlEhHLetNDAyHPvOdFYJJQbhxMAGN3BGHfKO8lE6bJ2zFDmTCIxLaIeOX5L9ynXRTPqY_INJJx2N18-DmO61ScXbGbWQ_cjUoHoAK6yyyljshKIUOMLAobLEyrIp5pxw_MujoBfLetKrZb1Y1qvlGvu4xrD-88lj0tl6DBadT2hLXcS_FGBnH7w18088YZ7iYwrVoaY6Mw36y1Lq0ilra5097Svgw78B_3__N6hjtM4
ContentType Journal Article
Copyright 2025
Copyright_xml – notice: 2025
DBID 6I.
AAFTH
AAYXX
CITATION
DOA
DOI 10.1016/j.identj.2025.105608
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EndPage 105608
ExternalDocumentID oai_doaj_org_article_469f28b8900c4c8c8ace7481103e0b30
10_1016_j_identj_2025_105608
S0020653925048919
1_s2_0_S0020653925048919
GroupedDBID ---
.1-
.FO
.GA
.Y3
05W
0R~
1OC
31~
3SF
50Z
52M
52U
52V
53G
5GY
8-0
8-1
8-3
8-4
8-5
930
A03
AAEDW
AAESR
AAEVG
AALRI
AAMMB
AANHP
AAONW
AAWTL
AAXUO
AAYWO
AAZKR
ABCUV
ABLJU
ABPVW
ACBWZ
ACGFO
ACGFS
ACMXC
ACPOU
ACPRK
ACRPL
ACVFH
ACXQS
ACYXJ
ADBBV
ADCNI
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADVLN
ADXAS
ADZMN
AEFGJ
AEIMD
AENEX
AEUPX
AFBPY
AFFNX
AFGKR
AFJKZ
AFPUW
AFRHN
AGQPQ
AGXDD
AHMBA
AIDQK
AIDYY
AIGII
AITUG
AIURR
AJAOE
AJUYK
AKBMS
AKRWK
AKYEP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMRAJ
AMYDB
APXCP
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BHBCM
BMXJE
BRXPI
CS3
D-E
D-F
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
EBS
EJD
F00
F01
F04
F5P
FDB
FEDTE
FUBAC
G-S
GK1
GODZA
GROUPED_DOAJ
H.T
H.X
HF~
HVGLF
HZ~
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
O66
O8X
O9-
OK1
P2P
P2W
P2X
PQQKQ
Q.N
QB0
R.K
ROL
RPM
SUPJJ
UB1
V8K
W8V
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
XG2
Z5R
ZGI
ZZTAW
~WT
6I.
AAFTH
AAYXX
CITATION
ID FETCH-LOGICAL-c3208-2144d3c56a0f2ef97a7c8484b4d4b2bdb321de3713f6de5ddc1e326e023605b73
IEDL.DBID DOA
ISSN 0020-6539
IngestDate Mon Nov 10 19:20:44 EST 2025
Sat Nov 29 06:57:16 EST 2025
Sat Nov 29 17:09:00 EST 2025
Sat Nov 29 12:11:03 EST 2025
Sat Nov 29 06:57:23 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords osseointegration
hyperlipidemia
osteoblasts
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3208-2144d3c56a0f2ef97a7c8484b4d4b2bdb321de3713f6de5ddc1e326e023605b73
OpenAccessLink https://doaj.org/article/469f28b8900c4c8c8ace7481103e0b30
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_469f28b8900c4c8c8ace7481103e0b30
crossref_primary_10_1016_j_identj_2025_105608
elsevier_sciencedirect_doi_10_1016_j_identj_2025_105608
elsevier_clinicalkeyesjournals_1_s2_0_S0020653925048919
elsevier_clinicalkey_doi_10_1016_j_identj_2025_105608
PublicationCentury 2000
PublicationDate October 2025
PublicationDateYYYYMMDD 2025-10-01
PublicationDate_xml – month: 10
  year: 2025
  text: October 2025
PublicationDecade 2020
PublicationTitle International dental journal
PublicationYear 2025
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
SSID ssj0048306
Score 2.4056025
Snippet Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to elucidate the...
Aim or purposeEndogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to...
Aim or purpose: Endogenous therapeutic targets for facilitating titanium implant osseointegration in hyperlipidemia remain elusive and this study aimed to...
SourceID doaj
crossref
elsevier
SourceType Open Website
Index Database
Publisher
StartPage 105608
SubjectTerms Dentistry
hyperlipidemia
osseointegration
osteoblasts
Title Overexpression Of Aldh6a1 Rescues Osteoblasts And Facilitates Osseointegration In Hyperlipidemia
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0020653925048919
https://www.clinicalkey.es/playcontent/1-s2.0-S0020653925048919
https://dx.doi.org/10.1016/j.identj.2025.105608
https://doaj.org/article/469f28b8900c4c8c8ace7481103e0b30
Volume 75
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  issn: 0020-6539
  databaseCode: DOA
  dateStart: 20210101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.doaj.org/
  omitProxy: false
  ssIdentifier: ssj0048306
  providerName: Directory of Open Access Journals
– providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  issn: 0020-6539
  databaseCode: DRFUL
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://onlinelibrary.wiley.com
  omitProxy: false
  ssIdentifier: ssj0048306
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQIMGlokDFFop84Bo1iZ21c1ygK5AQWyFA3Iw_xioIZdFmQfz8ju2kyqHSXrjkkMR28sbxvFHGbwg54WCEL0yZcQM8Q389zrSWeHBe1pUXgsW9VfdX4vpaPjzUvwelvkJOWJIHTsD9xPDNl9LIOs8tt9JKbUFwiV6LQW5YjNaR9fTBVFqDuWSxqmYeg6OK1f2muZjZFap1Lp8xNiyrWHg-lJYcOKWo3T_wTQN_M90hXzqiSCfpAb-SNWh2ydZ5SO4J9dn2yOMMZyF8dImsDZ15Onlxf8a6oDfQWlzu6QxNODfIj5ctnTSOTrVNotzxWgvzXiwitL9s6AUGpYuXp1Q0Vu-Tu-mv27OLrKuXkFmGGGRB_cwxW4117kvwtdDCSi654Y6b0jjDysIBw7DUjx1UztkCkL1BEJHPKyPYN7LezBs4IJQ5JiVDtlOD5BZJhbWWA2KOtvCaVSOS9YCp1ySLofp8sWeVAFYBYJUAHpHTgOq_e4OodTyBpladqdUqU49I1dtE9ftGcaXDjp5WDC7-1w7a7nNtVaHaUuUq_LmOWr1B103WRT1s2TGSxDRWjvn9M174kGyHLlPu4BFZXy7e4AfZtO840xbHccYfk43zm-nd1V9vvwSC
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+Of+Aldh6a1+Rescues+Osteoblasts+And+Facilitates+Osseointegration+In+Hyperlipidemia&rft.jtitle=International+dental+journal&rft.au=Wang%2C+Ya-nan&rft.au=Liu%2C+Shiyue&rft.date=2025-10-01&rft.pub=Elsevier+Inc&rft.issn=0020-6539&rft.volume=75&rft_id=info:doi/10.1016%2Fj.identj.2025.105608&rft.externalDocID=S0020653925048919
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00206539%2FS0020653925X00071%2Fcov150h.gif